Best of The Oncologist 2018


以乳腺癌、肺癌、肝癌和胃肠道肿瘤为主要内容,重点关注了《肿瘤学家》杂志在过去一年中发表的最有影响力的临床发现及综述文献。不断进步的肿瘤研究需要临床肿瘤学家永远站在治疗方案进展的第一线,才能延长患者生命并改善结局。没有一本期刊像《肿瘤学家》杂志一样,将对患者结局的重视与多学科广度放到同一高度,这使它成为医生和研究者的必备学术资源。

This collection highlights the most impactful clinical findings and review articles published in The Oncologist in the past year, with a focus on breast, lung, liver, and gastrointestinal malignancies. The ever-evolving world of cancer research requires the clinical oncologist to stay abreast of treatment decisions that can extend and improve their patients’ lives. No journal combines the same multidisciplinary breadth and emphasis on patient outcomes as The Oncologist, making it an essential resource for practitioners and researchers alike.


Featured Articles


Global Health and Cancer

The Implementation and First‐Round Results of a Community‐Based Colorectal Cancer Screening Program in Shanghai, China
Yangming Gong, Peng Peng, Pingping Bao, Weijian Zhong, Yan Shi, Kai Gu, Ying Zheng, Chunxiao Wu, Sanjun Cai, Ye Xu, Jun Sheng and Fan Wu
The Oncologist 2018; first published on March 14, 2018; doi: 10.1634/theoncologist.2017-0451

Commentary

Important Role of Health Surveillance Systems in Community‐Based Colorectal Cancer Screening
Ann Chao, Sudha Sivaram
The Oncologist 2018; first published on July 26, 2018; doi:10.1634/theoncologist.2018-0178




Breast Cancer

Ki67 Changes Identify Worse Outcomes in Residual Breast Cancer Tumors After Neoadjuvant Chemotherapy
Paula Cabrera‐Galeana, Wendy Muñoz‐Montaño, Fernando Lara‐Medina, Alberto Alvarado‐Miranda, Victor Pérez‐Sánchez, Cynthia Villarreal‐Garza, R. Marisol Quintero, Fany Porras‐Reyes, Enrique Bargallo‐Rocha, Ignacio Del Carmen, Alejandro Mohar, Oscar Arrieta
The Oncologist 2018; 23:871-873; first published on July 26, 2018; doi:10.1634/theoncologist.2017-0396

Amyloid Precursor Protein Is Associated with Aggressive Behavior in Nonluminal Breast Cancers
Julia Y.S. Tsang, Michelle A. Lee, Yun‐Bi Ni, Siu‐Ki Chan, Sai‐Yin Cheung, Wai‐Wa Chan, Kwok‐Fai Lau, Gary M.K. Tse
The Oncologist first published on August 14, 2018; doi:10.1634/theoncologist.2018-0012

Head and Neck Cancer

10‐Year Results of Therapeutic Ratio by Intensity‐Modulated Radiotherapy Versus Two‐Dimensional Radiotherapy in Patients with Nasopharyngeal Carcinoma
Lei Chen, Yuan Zhang, Shu‐Zhen Lai, Wen‐Fei Li, Wei‐Han Hu, Rui Sun, Li‐Zhi Liu, Fan Zhang, Hao Peng, Xiao‐Jing Du, Ai‐Hua Lin, Ying Sun, Jun Ma
The Oncologist first published on August 6, 2018; doi:10.1634/theoncologist.2017-0577

Hematologic Malignancies

Validation and Refinement of the Age, Comorbidities, and Albumin Index in Elderly Patients with Diffuse Large B‐Cell Lymphoma: An Effective Tool for Comprehensive Geriatric Assessment
Hui Liu, Chun‐Li Zhang, Ru Feng, Jiang‐Tao Li, Yuan Tian, Ting Wang
The Oncologist 2018; 23:722-729; first published on January 9, 2018; doi:10.1634/theoncologist.2017-0361

Hepatobiliary

Next‐Generation Sequencing of Circulating Tumor DNA Reveals Frequent Alterations in Advanced Hepatocellular Carcinoma
Sadakatsu Ikeda, Igor F. Tsigelny, Åge A. Skjevik, Yuko Kono, Michel Mendler, Alexander Kuo, Jason K. Sicklick, Gregory Heestand, Kimberly C. Banks, AmirAli Talasaz, Richard B. Lanman, Scott Lippman, Razelle Kurzrock
The Oncologist 2018; 23:586-593; first published on February 27, 2018; doi:10.1634/theoncologist.2017-0479

Lung Cancer

A Randomized Phase II Study of Metformin plus Paclitaxel/Carboplatin/Bevacizumab in Patients with Chemotherapy‐Naïve Advanced or Metastatic Nonsquamous Non‐Small Cell Lung Cancer
Kristen A. Marrone, Xian Zhou, Patrick M. Forde, Michael Purtell, Julie R. Brahmer, Christine L. Hann, Ronan J. Kelly, Barbara Coleman, Edward Gabrielson, Gary L. Rosner, David S. Ettinger
The Oncologist 2018; 23:859-865; first published on February 27, 2018; doi:10.1634/theoncologist.2017-0465

Comprehensive Computed Tomography Radiomics Analysis of Lung Adenocarcinoma for Prognostication
Geewon Lee, Hyunjin Park, Insuk Sohn, Seung‐Hak Lee, So Hee Song, Hyeseung Kim, Kyung Soo Lee, Young Mog Shim, Ho Yun Lee
The Oncologist 2018; 23:806-813; first published on April 5, 2018; doi:10.1634/theoncologist.2017-0538

Symptom Management and Supportive Care

Olanzapine‐Based Triple Regimens Versus Neurokinin‐1 Receptor Antagonist‐Based Triple Regimens in Preventing Chemotherapy‐Induced Nausea and Vomiting Associated with Highly Emetogenic Chemotherapy: A Network Meta‐Analysis
Zhonghan Zhang, Yaxiong Zhang, Gang Chen, Shaodong Hong, Yunpeng Yang, Wenfeng Fang, Fan Luo, Xi Chen, Yuxiang Ma, Yuanyuan Zhao, Jianhua Zhan, Cong Xue, Xue Hou, Ting Zhou, Shuxiang Ma, Fangfang Gao, Yan Huang, Likun Chen, Ningning Zhou, Hongyun Zhao, Li Zhang
The Oncologist 2018; 23:603-616; first published on January 12, 2018; doi:10.1634/theoncologist.2017-0378